MENU
+Compare
HAE
Stock ticker: NYSE
AS OF
Apr 25 closing price
Price
$62.51
Change
+$0.59 (+0.95%)
Capitalization
4.33B

HAE Haemonetics Corp Forecast, Technical & Fundamental Analysis

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces... Show more

HAE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for HAE with price predictions
Apr 25, 2025

HAE's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for HAE turned positive on April 23, 2025. Looking at past instances where HAE's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where HAE's RSI Indicator exited the oversold zone, of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 22, 2025. You may want to consider a long position or call options on HAE as a result. In of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HAE advanced for three days, in of 329 cases, the price rose further within the following month. The odds of a continued upward trend are .

HAE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HAE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for HAE entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.564) is normal, around the industry mean (10.413). P/E Ratio (34.467) is within average values for comparable stocks, (81.243). Projected Growth (PEG Ratio) (1.624) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (3.428) is also within normal values, averaging (41.902).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. HAE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HAE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
HAE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

HAE is expected to report earnings to rise 2.52% to $1.22 per share on May 08

Haemonetics Corp HAE Stock Earnings Reports
Q1'25
Est.
$1.22
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.05
Q2'24
Beat
by $0.01
Q1'24
Beat
by $0.01
The last earnings report on February 06 showed earnings per share of $1.19, beating the estimate of $1.17. With 446.46K shares outstanding, the current market capitalization sits at 4.33B.
A.I. Advisor
published General Information

General Information

a manufacturer of blood processing systems

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
125 Summer Street
Phone
+1 781 848-7100
Employees
3034
Web
https://www.haemonetics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CUBA2.470.03
+1.23%
Herzfeld Caribbean Basin Fund
BDJ8.250.05
+0.61%
BlackRock Enhanced Equity Dividend Trust
YJUN23.160.01
+0.05%
FT Vest Intl Eq Mod Bf ETF June
SIJ8.32N/A
N/A
ProShares UltraShort Industrials
GXC81.95-0.24
-0.29%
SPDR® S&P China ETF

HAE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HAE has been loosely correlated with ATR. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if HAE jumps, then ATR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAE
1D Price
Change %
HAE100%
+0.95%
ATR - HAE
38%
Loosely correlated
-1.58%
GH - HAE
38%
Loosely correlated
+1.88%
CNMD - HAE
36%
Loosely correlated
-0.57%
HOLX - HAE
35%
Loosely correlated
-0.46%
A - HAE
34%
Loosely correlated
-0.69%
More